BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24023357)

  • 41. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal.
    Huang K; Haas-Kogan D; Weinberg V; Krieg R
    World J Gastroenterol; 2007 Feb; 13(6):895-900. PubMed ID: 17352019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anal cancer chemoirradiation with curative intent - a single institution experience.
    Oblak I; Petric P; Anderluh F; Velenik V; Hudej R; Fras AP
    Neoplasma; 2009; 56(2):150-5. PubMed ID: 19239330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy.
    Allal AS; Mermillod B; Roth AD; Marti MC; Kurtz JM
    Cancer; 1997 Jun; 79(12):2329-35. PubMed ID: 9191520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups.
    Bosset JF; Roelofsen F; Morgan DA; Budach V; Coucke P; Jager JJ; Van der Steen-Banasik E; Trivière N; Stüben G; Puyraveau M; Mercier M;
    Eur J Cancer; 2003 Jan; 39(1):45-51. PubMed ID: 12504657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience.
    Chapet O; Gerard JP; Mornex F; Goncalves-Tavan S; Ardiet JM; D'hombres A; Favrel V; Romestaing P
    Int J Colorectal Dis; 2007 Feb; 22(2):191-9. PubMed ID: 16799791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-dose considerations in the treatment of anal cancer.
    Constantinou EC; Daly W; Fung CY; Willett CG; Kaufman DS; DeLaney TF
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):651-7. PubMed ID: 9336145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.
    Hu K; Minsky BD; Cohen AM; Kelsen DP; Guillem JG; Paty PP; Quan SH
    J Surg Oncol; 1999 Feb; 70(2):71-7. PubMed ID: 10084647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.
    Siegel EM; Eschrich S; Winter K; Riggs B; Berglund A; Ajidahun A; Simko J; Moughan J; Ajani J; Magliocco A; Elahi A; Hoffe S; Shibata D
    Dis Colon Rectum; 2014 Aug; 57(8):941-57. PubMed ID: 25003289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
    J Clin Oncol; 2009 Mar; 27(7):1116-21. PubMed ID: 19139424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection.
    Höcht S; Wiegel T; Kroesen AJ; Berdel WE; Runkel N; Hinkelbein W
    Acta Oncol; 1997; 36(8):799-802. PubMed ID: 9482685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery.
    Kim BK; Kim KJ; Ahn YC; Lim DH; Park W; Han J; Park K; Kim KM; Kim J; Shim YM
    Cancer Res Treat; 2003 Dec; 35(6):497-501. PubMed ID: 26680981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network.
    Belkacémi Y; Berger C; Poortmans P; Piel G; Zouhair A; Méric JB; Nguyen TD; Krengli M; Behrensmeier F; Allal A; De Looze D; Bernier J; Scandolaro L; Mirimanoff RO;
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1274-83. PubMed ID: 12873671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience].
    Osti MF; Agolli L; Scaringi C; Bracci S; Minniti G; Maurizi Enrici R
    Radiol Med; 2013 Aug; 118(5):882-94. PubMed ID: 23184242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study.
    Sunesen KG; Nørgaard M; Lundby L; Havsteen H; Buntzen S; Thorlacius-Ussing O; Laurberg S
    J Clin Oncol; 2011 Sep; 29(26):3535-40. PubMed ID: 21825256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anal Carcinoma.
    Szilagy EJ; Farid A
    Curr Treat Options Gastroenterol; 2001 Jun; 4(3):275-279. PubMed ID: 11469985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anal carcinoma: surgery does not influence prognosis when performed prior to concurrent radiochemotherapy.
    Badakhshi H; Budach V; Wust P; Graf R
    Anticancer Res; 2013 Sep; 33(9):4111-5. PubMed ID: 24023357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
    Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
    Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.